BEN-MAIMON CAROLE (President and CEO) received a stock award from LARIMAR THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/19/2024ACC: 0001062993-24-001083
DirectorOfficer· President and CEO
Since May 2020
+462.88K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
462.88K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+66.13K
Price / share
—
Trade value
—
% of position
24.8%
1/17/2024
266.83K→332.95K
Total
Net shares
+66.13K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2024 | A · Award | +66.13K | — | — | 24.8% | 266.83K | 332.95K |
| Total | +66.13K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
396.75K shares
Shares
+396.75K
Strike price
4.21
Held after
396.75K
Exercisable
—
1/17/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock396.75K shares | 1/17/2024 | A · Award | +396.75K | 4.21 | — | 396.75K |